ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 205 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $269,000 | -29.8% | 6,660 | 0.0% | 0.01% | -25.0% |
| Q2 2015 | $383,000 | -11.3% | 6,660 | -1.9% | 0.02% | -15.8% |
| Q1 2015 | $432,000 | -46.3% | 6,790 | -47.9% | 0.02% | -45.7% |
| Q4 2014 | $805,000 | +59.1% | 13,040 | 0.0% | 0.04% | +59.1% |
| Q3 2014 | $506,000 | +12.7% | 13,040 | 0.0% | 0.02% | +10.0% |
| Q2 2014 | $449,000 | -36.6% | 13,040 | -6.1% | 0.02% | -39.4% |
| Q1 2014 | $708,000 | +28.0% | 13,890 | 0.0% | 0.03% | +26.9% |
| Q4 2013 | $553,000 | +6.1% | 13,890 | 0.0% | 0.03% | -3.7% |
| Q3 2013 | $521,000 | -11.4% | 13,890 | -36.5% | 0.03% | -15.6% |
| Q2 2013 | $588,000 | – | 21,880 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |